Ofatumumab

Ofatumumab is a medication used to treat certain autoimmune diseases, particularly multiple sclerosis (MS). It works by targeting and depleting specific immune cells (B cells) that contribute to the disease's harmful effects. By reducing these cells, Ofatumumab can help lessen symptoms and slow disease progression. It is administered through injections, typically under the supervision of a healthcare provider. Its use represents a targeted approach in managing autoimmune conditions, aiming to improve patients' quality of life and reduce flare-ups or relapses.